Search
Feed aggregator
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS 4/5/2024
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy 4/5/2024
Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters
Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters 4/5/2024
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data 4/5/2024
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales 4/23/2024
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win 4/23/2024
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates 4/23/2024
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC 4/23/2024
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data 4/23/2024
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva 4/23/2024
Incyte Breaks Mid-April M&A Lull With Escient Purchase
Incyte Breaks Mid-April M&A Lull With Escient Purchase 4/23/2024
Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff 4/23/2024
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment 4/23/2024
Researchers develop a new way to safely boost immune cells to fight cancer
Cancer is the monster of our society. Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped medical progress on developing treatment procedures that are less invasive while still highly effective.
Immunotherapy is on the rise as a possible solution. Immunotherapy involves harnessing the power of the body's immune system to fight against cancer cells.
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US 4/19/2024
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024
World Pharma News
- Researchers develop a new way to safely boost immune cells to fight cancer
- How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
- Common HIV treatments may aid Alzheimer's disease patients
- AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson's disease
- Next-generation treatments hitch a ride into cancer cells